These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


789 related items for PubMed ID: 16720588

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The relationship between health plan advertising and market incentives: evidence of risk-selective behavior.
    Mehrotra A, Grier S, Dudley RA.
    Health Aff (Millwood); 2006; 25(3):759-65. PubMed ID: 16684741
    [Abstract] [Full Text] [Related]

  • 24. Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
    Austin BJ.
    Find Brief; 2008 Nov; 11(8):1-3. PubMed ID: 19035029
    [Abstract] [Full Text] [Related]

  • 25. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B.
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE, Sullivan SD.
    Health Aff (Millwood); 2005 Aug; 24(4):1032-8. PubMed ID: 16012143
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
    Fise T.
    Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
    [No Abstract] [Full Text] [Related]

  • 32. Overview of Medicare Part D prescription drug benefit: potential implications for patients with psychotic disorders.
    Rosenberg JM.
    Am J Health Syst Pharm; 2007 Jan 15; 64(2 Suppl 1):S18-23; quiz S24-5. PubMed ID: 17215472
    [Abstract] [Full Text] [Related]

  • 33. Who will be denied Medicare prescription drug subsidies because of the asset test?
    Rice T, Desmond K.
    Am J Manag Care; 2006 Jan 15; 12(1):46-54. PubMed ID: 16402888
    [Abstract] [Full Text] [Related]

  • 34. Perverse incentives in the Medicare prescription drug benefit.
    McAdams D, Schwarz M.
    Inquiry; 2007 Jan 15; 44(2):157-66. PubMed ID: 17850042
    [Abstract] [Full Text] [Related]

  • 35. The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
    Evans-Molina C, Regan S, Henault LE, Hylek EM, Schwartz GR.
    J Am Geriatr Soc; 2007 Jul 15; 55(7):1038-43. PubMed ID: 17608876
    [Abstract] [Full Text] [Related]

  • 36. A prescription for a modern Medicare program.
    Bach PB, McClellan MB.
    N Engl J Med; 2005 Dec 29; 353(26):2733-5. PubMed ID: 16382056
    [No Abstract] [Full Text] [Related]

  • 37. Medicare Part D: practical practice information for healthcare providers.
    Moczygemba LR.
    J Am Acad Nurse Pract; 2006 Oct 29; 18(10):457-62. PubMed ID: 16999710
    [Abstract] [Full Text] [Related]

  • 38. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML.
    Policy Polit Nurs Pract; 2007 Aug 29; 8(3):170-81. PubMed ID: 18178923
    [Abstract] [Full Text] [Related]

  • 39. Savings from drug discount cards: relief for Medicare beneficiaries?
    Cubanski J, Frank RG, Epstein AM.
    Health Aff (Millwood); 2004 Aug 29; Suppl Web Exclusives():W4-198-209. PubMed ID: 15451980
    [Abstract] [Full Text] [Related]

  • 40. Prescription drugs in Medicare and the ESRD program.
    Powe NR.
    Semin Nephrol; 2000 Nov 29; 20(6):535-42. PubMed ID: 11111855
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 40.